Comparison of the Effects of Heparin and Hirudin on Thrombin Binding to the Normal and the De-Endothelialized Rabbit Aorta In Vitro

Summary

The properties of heparin and hirudin to inhibit thrombin from binding to the freshly-excised rabbit aorta wall were compared in vitro. When aorta segments were incubated with ¹²⁵I-thrombin (4.4 ± 0.4 nM) in the presence of heparin or hirudin, both anticoagulants inhibited ¹²⁵I-thrombin binding to the endothelium in a concentration-dependent manner (IC₅₀: 0.1 USP U heparin/ml; 0.1 ATU hirudin/ml). Endothelium-bound ¹²⁵I-thrombin was displaced by either heparin (50% liberated at 4.1 U/ml) or hirudin (0.4 U/ml). Using de-endothelialized aortas, heparin inhibited thrombin binding by the exposed subendothelium (IC₅₀: 1.8 U/ml) whereas hirudin was without effect. Neither heparin nor hirudin was able to significantly liberate thrombin bound to the exposed subendothelium. These observations suggest that both heparin and hirudin mask the binding site on thrombin to the endothelial cell membrane. A separate site on thrombin must bind to the subendothelium because only heparin inhibits binding. Thrombin, although bound reversibly to the endothelium, is bound irreversibly to the exposed subendothelium due, probably, to reaction with endogenous extracellular antithrombin activities (e.g. antithrombin-III, protease nexin-1).

• References

• 1 Jaques LB. Heparins – Anionic polyelectrolyte drugs. Pharmacol Rev 1980; 31: 99-166
• 2 Hatton MWC, Dejana E, Cazenave J-P, Regoeczi E, Mustard JF. Heparin inhibits thrombin binding to rabbit thoracic aorta endothelium. J Lab Clin Med 1980; 96: 861-70
• 3 Hatton MWC, Moar SL. Displacement of FPR-thrombin, but not antithrombin III, from the rabbit blood vessel wall in vivo.. Circulation 1988; 78 Suppl II 253 (Abstr)
• 4 Hatton MWC, Moar SL. Comparative behaviour of thrombin and an inactive derivative, FPR-thrombin, towards rabbit vascular endothelium: Heparin liberates FPR-thrombin from the endothelium in vivo. Circulation Res 1990; 67: 221-9
• 5 Markwardt F. Hirudin as an inhibitor of thrombin. Meth Enzymol 1970; XIX: 924-32
• 6 Mao SJT, Yates MT, Owen TJ, Krstenansky JL. Interaction of hirudin with thrombin: Identification of a minimal binding domain of hirudin that inhibits clotting activity. Biochemistry 1988; 27: 8170-3
• 7 Talbot M. Biology of recombinant hirudin (CPG 39393): A new prospect in the treatment of thrombosis. Semin Thromb Hemostas 1989; 15: 293-301
• 8 Jakubowski JA, Maraganore JM. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy terminus of Hirudin. Blood 1990; 75: 399-406
• 9 Maraganore JM, Chao B, Joseph ML, Jablonski J, Ramachandran KL. Anticoagulant activity of synthetic hirudin peptides. J Biol Chem 1989; 264: 8692-8
• 10 Hatton MWC, Berry LR, Regoeczi E. Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta. Thromb Res 1977; 10: 645-60
• 11 Hatton MWC, Moar SL, Richardson M. On the interaction of rabbit antithrombin III with the luminal surface of the normal and de-endothelialized rabbit thoracic aorta in vitro. Blood 1986; 67: 878-86
• 12 Hatton MWC, Moar SL. Uptake and catabolism of ¹²⁵I-thrombin by the rabbit thoracic aorta in vitro: Permeability of the endothelium, intima-media and adventitial layers. Thromb Haemostas 1984; 52: 105-11
• 13 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5
• 14 U.S. Pharmacopeia and National Formulary 1985 XXI. 482
• 15 Hatton MWC, Moar SL, Richardson M. Behavior of plasminogen at the luminal surface of the normal and de-endothelialized rabbit aorta in vivo and in vitro. Blood 1988; 71: 1260-7
• 16 Pugatch EMJ, Saunders AM. A new technique for making Hautchen preparations of unfixed aortic endothelium. J Atheroscler Res 1968; 8: 735-8
• 17 Stone SR, Hofsteenge J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry 1986; 25: 4622-8
• 18 Griffith MJ, Kingdon HS, Lundblad RL. The interaction of heparin with human a-thrombin: Effect on the hydrolysis of anilide tripeptide substrates. Arch Biochem Biophys 1979; 195: 378-84
• 19 Griffith MJ. Covalent modification of human a-thrombin with pyridoxal 5'-phosphate: Effect of phosphopyridoxylation on the interaction of thrombin with heparin. J Biol Chem 1979; 254: 3401-6
• 20 Konno S, Fenton JW, Villanueva GB. Analysis of the secondary structure of hirudin and the mechanism of its interaction with thrombin. Arch Biochem Biophys 1988; 267: 158-66
• 21 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-64
• 22 Hofsteenge J, Taguchi H, Stone SR. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Biochem J 1986; 237: 243-51
• 23 Stone SR, Hofsteenge J. Effect of heparin on the interaction between thrombin and hirudin. Eur J Biochem 1987; 169: 373-6
• 24 Hatton MWC, Moar SL, Richardson M. Evidence that rabbit ¹²⁵I-antithrombin III binds to proteoheparan sulphate at the subendothelium of the rabbit aorta in vitro. Blood Vessels 1988; 25: 12-27
• 25 Low DA, Baker JB, Koonce WC, Cunningham DD. Released protease nexin regulates cellular binding, internalisation, and degradation of serine proteases. Proc Natl Acad Sci USA 1981; 78: 2340-4
• 26 Hatton MWC, Moar SL, Richardson M. Enhanced binding of fibrinogen by the subendothelium after treatment of the rabbit aorta with thrombin. J Lab Clin Med 1990; 115: 356-64
• 27 Heras M, Chesebro JH, Penny WJ, Bailey KR, Badimon L, Fuster V. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 1989; 79: 657-65